Patents by Inventor Tilde Eskildsen

Tilde Eskildsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MODULATION OF MICRORNA-138 FOR THE TREATMENT OF BONE LOSS
    Publication number: 20160355804
    Abstract: There is provided nucleic acids (mir-138Antimirs) for use in treating or preventing bone loss in a patient. Also there is provided a method for reducing the levels of endogenous mir-138 in a cell.
    Type: Application
    Filed: January 7, 2016
    Publication date: December 8, 2016
    Inventors: Moustapha KASSEM, Basem ABDALLAH, Hanna TAIPALEENMAEKI, Sakari KAUPPINEN, Tilde ESKILDSEN, Jan STENVANG
  • MODULATION OF MICRORNA-138 FOR THE TREATMENT OF BONE LOSS
    Publication number: 20140194491
    Abstract: There is provided nucleic acids (mir-138 Antimirs) for use in treating or preventing bone loss in a patient. Also there is provided a method for reducing the levels of endogenous mir-138 in a cell.
    Type: Application
    Filed: June 11, 2012
    Publication date: July 10, 2014
    Applicant: SYDDANSK UNIVERSITET
    Inventors: Moustapha Kassem, Basem Abdallah, Hanna Taipaleenmaeki, Sakari Kauppinen, Tilde Eskildsen, Jan Stenvang